Olivier Feron
Olivier Feron
Verified email at
Cited by
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
F Danhier, O Feron, V Préat
Journal of controlled release 148 (2), 135-146, 2010
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
P Sonveaux, F Végran, T Schroeder, MC Wergin, J Verrax, ZN Rabbani, ...
The Journal of clinical investigation 118 (12), 3930-3942, 2008
Nitric oxide synthases: which, where, how, and why?
T Michel, O Feron
The Journal of clinical investigation 100 (9), 2146-2152, 1997
Endothelial nitric oxide synthase targeting to caveolae: specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells
O Feron, L Belhassen, L Kobzik, TW Smith, RA Kelly, T Michel
Journal of Biological Chemistry 271 (37), 22810-22814, 1996
Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis
F Végran, R Boidot, C Michiels, P Sonveaux, O Feron
Cancer research 71 (7), 2550-2560, 2011
Nitric oxide and cardiac function: ten years after, and continuing
PB Massion, O Feron, C Dessy, JL Balligand
Circulation research 93 (5), 388-398, 2003
Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin
JB Michel, O Feron, D Sacks, T Michel
Journal of Biological Chemistry 272 (25), 15583-15586, 1997
Tumour acidosis: from the passenger to the driver's seat
C Corbet, O Feron
Nature Reviews Cancer 17 (10), 577-593, 2017
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation
F Danhier, N Lecouturier, B Vroman, C Jérôme, J Marchand-Brynaert, ...
Journal of controlled release 133 (1), 11-17, 2009
Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells
O Feron
Radiotherapy and oncology 92 (3), 329-333, 2009
Hydroxy-methylglutaryl–coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance
O Feron, C Dessy, JP Desager, JL Balligand
Circulation 103 (1), 113-118, 2001
A roadmap for interpreting 13C metabolite labeling patterns from cells
JM Buescher, MR Antoniewicz, LG Boros, SC Burgess, H Brunengraber, ...
Current opinion in biotechnology 34, 189-201, 2015
eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues
JL Balligand, O Feron, C Dessy
Physiological reviews 89 (2), 481-534, 2009
A mitochondrial switch promotes tumor metastasis
PE Porporato, VL Payen, J Pérez-Escuredo, CJ De Saedeleer, P Danhier, ...
Cell reports 8 (3), 754-766, 2014
Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis
P Sonveaux, T Copetti, CJ De Saedeleer, F Vegran, J Verrax, ...
PloS one 7 (3), e33418, 2012
Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
O Feron, C Dessy, S Moniotte, JP Desager, JL Balligand
The Journal of clinical investigation 103 (6), 897-905, 1999
Upregulation of β3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium
S Moniotte, L Kobzik, O Feron, JN Trochu, C Gauthier, JL Balligand
Circulation 103 (12), 1649-1655, 2001
The endothelial nitric-oxide synthase-caveolin regulatory cycle
O Feron, F Saldana, JB Michel, T Michel
Journal of Biological Chemistry 273 (6), 3125-3128, 1998
Caveolin versus calmodulin: counterbalancing allosteric modulators of endothelial nitric oxide synthase
JB Michel, O Feron, K Sase, P Prabhakar, T Michel
Journal of Biological Chemistry 272 (41), 25907-25912, 1997
The system can't perform the operation now. Try again later.
Articles 1–20